Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-emptive Scalp Infiltration with Flurbiprofen Axetil and Ropivacaine for Post-Craniotomy Analgesia
NCT07209345Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Oct 2025
- Primary completion
- Oct 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of flurbiprofen axetil in postoperative pain (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Cumulative sufentanil consumption in PCIA device at 48 hours. Started Oct 2025; status: recruiting.
02
Drugs
flurbiprofen axetil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07209345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07209345.